White blood cell count and cardiovascular biomarkers of atherosclerosis

Biomarkers

Volumn 15, Issue 5, 2010, Pages 454-460

  Sekitani, Yui ^a   Hayashida, Naomi ^a   Kadota, Koichiro ^a   Yamasaki, Hironori ^b   Abiru, Norio ^a   Nakazato, Mio ^a   Maeda, Takahiro ^a   Ozono, Yoshiyuki ^a   Takamura, Noboru ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cardio ankle vascular index; Carotid intimamedia thickness; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; LIPID;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; JAPANESE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PARAMETER; POPULATION;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CAROTID ARTERIES; CHOLESTEROL, HDL; CREATININE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEUKOCYTE COUNT; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEX FACTORS; SMOKING; TRIGLYCERIDES; TUNICA MEDIA;

EID: 77954839087     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.486870     Document Type: Article

References (34)

1. Blacher J, Asmar R, Djane S, London GM, Safar ME. (1999). Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33:1111-1117
2. Bots ML, Grobbee DE. (2002). Intima media thickness as a surrogate marker for generalized atherosclerosis. Cardiovasc Drugs Ther 16:341-351
3. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. (1997). Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 96:1432-1437
4. Crook M. (2004). Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabet Med 21:203-207
5. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W. (1997). Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 82:4196-4200
6. Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
7. Friedman GD, Fireman BH. (1991). The leukocyte count and cancer mortality. Am J Epidemiol 133:376-380
8. Grimm RH, Neaton JD, Ludwig W. (1985). Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 254:1932-1937
9. Gustavsson CG, Agardh CD. (2004). Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. Eur Heart J 25:2120-2124
10. Hansen LK, Grimm RH Jr, Neaton JD. (1990). The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 19:881-888
11. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. (2004). Leukocytes and coronary heart disease. Atherosclerosis 172:1-6
12. Huang ZS, Jeng JS, Wang CH, Yip PK, Wu TH, Lee TK. (2001). Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 158:431-436
13. Kadota K, Takamura N, Aoyagi K, Yamasaki H, Usa T, Nakazato M, Maeda T, Wada M, Nakashima K, Abe K, Takeshima F, Ozono Y. (2008). Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J 72:304-308
14. Koh KK. (2002). Effects of estrogen on vascular wall: vasomotor function and inflammation. Cardiovasc Res 55: 714-726
15. Lao XQ, Thomas GN, Jiang C, Zhang W, Adab P, Lam TH, Cheng KK. (2008). White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis 201:418-424
16. Lee YJ, Lee JW, Kim JK, Lee JH, Kim JH, Kwon KY, Lee HR, Lee DC, Shim JY. (2009). Elevated white blood cell count is associated with arterial stiffness. Nutr Metab Cardiovasc Dis 19:3-7.
17. Loimaala A, Rontu R, Vuoli I, Mercuri M, Lehtimäki T, Nenonen A, Bond MG. (2006) Blood leukocyte count is a risk factor for intima- media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis 188:363-369
18. Madjid M, Awan I, Willerson JT, Casscells SW. (2004). Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44:1945-1956
19. Magyar MT, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S, Balla G, Jeney V, Csiba L, Bereczki D. (2003). Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 34:58-63.
20. Petitti DB, Kipp H. (1986). The leukocyte count: associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 123:89-95.
21. Pocock SJ, Ashby D, Shaper AG, Walker M, Broughton PM. (1989). Diurnal variations in serum biochemical and hematological measurements. J Clin Pathol 42:172-179
22. Prentice RL, Szatrowski TP, Fujikura T, Kato H, Mason MW, Hamilton HH. (1982). Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 116:496-509.
23. Prentice RL, Szatrowski TP, Kato H, Mason MW. (1982). Leukocyte counts and cerebrovascular disease. J Chronic Dis 35: 703-714
24. Ross R. (1999). Atherosclerosis - an inflammatory disease. N Engl Med 340:115-126
25. Saito I, Yonemasu K, Inami F. (2003). Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J 67:323-329
26. Shankar A, Klein BE, Klein R. (2004). Relationship between white blood cell count and incident hypertension. Am J Hypertens 17:233-239
27. Shirai K, Utino J, Otsuka K, Takata M. (2006). A novel blood pressureindependent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 13:101-107
28. Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto T, Yamane K, Kohno N. (2005). Pulse wave velocity predicts cardiovascular mortality: Findings from the Hawaii-Los Angeles-Hiroshima study. Circ J 69:259-264
29. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks APG, van der Kuip DAM, Hofman A, Witteman JCM. (2001). Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke 32:454-460 (Pubitemid 32155234)
30. Vincent MA, Montagnani M, Quon MJ. (2003). Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 3:279-288
31. Vogel RA, Benitez MR. (2000). Noninvasive assessment of cardiovascular risk: from Framingham to the future. Rev Cardiovasc Med 1:34-42.
32. Wakabayashi I, Masuda H. (2006). Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clinica Chimica Acta 365:230-235 (Pubitemid 43196443)
33. Wilson PWF, Garrison RJ, Abbott RD, Castelli WP. (1983). Factors associated with lipoprotein cholesterol levels. Arteriosclerosis 3:273-281
34. Yambe T, Yoshizawa M, Saijo Y, Yamaguchi T, Shibata M, Konno S, Nitta S, Kuwayama T. (2004). Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother 58:S95-8.